Stockscreener 앱 받기
43.69
0.21%
-0.09
시간 외 거래:
43.75
0.06
+0.14%
전일 마감가:
$43.78
열려 있는:
$43.54
하루 거래량:
1.51M
Relative Volume:
0.72
시가총액:
$8.23B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
43.69
EPS:
1
순현금흐름:
$232.07M
1주 성능:
+0.09%
1개월 성능:
-14.28%
6개월 성능:
-27.68%
1년 성능:
-25.21%
1일 변동 폭
$43.46
$43.90
1주일 범위
$43.25
$45.40
52주 변동 폭
$43.25
$85.21
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
43.69 | 8.24B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
224.65 | 36.68B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
62.70 | 11.43B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
93.48 | 7.90B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.75 | 6.80B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
How Doximity Inc stock reacts to global recession fears2025 Earnings Surprises & Reliable Intraday Trade Plans - moha.gov.vn
Rice Hall James & Associates LLC Sells 35,852 Shares of Doximity, Inc. $DOCS - MarketBeat
HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Doximity (NASDAQ:DOCS) Sets New 1-Year LowHere's Why - MarketBeat
Doximity (DOCS) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Doximity stock hits 52-week low at 43.28 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.28 USD - Investing.com
Doximity (DOCS) Stock Trades Up, Here Is Why - Finviz
Why Doximity (DOCS) is a Top Growth Stock for the Long-Term - Nasdaq
Riverbridge Partners LLC Has $40.61 Million Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Why BofA Sees Strong Upside for Doximity (DOCS) - Finviz
BTIG Upgrades Doximity (DOCS) Stock to Buy from Neutral - MSN
Is Doximity Inc. stock attractive for long term wealth buildingJuly 2025 Reactions & Community Driven Trade Alerts - bolumsonucanavari.com
Is Doximity Inc. Class stock considered safe havenJuly 2025 Institutional & Target Return Focused Stock Picks - Улправда
Doximity, Inc. $DOCS Shares Purchased by Voya Investment Management LLC - MarketBeat
Clinical decision support's new chessboard - Axios
Will Doximity Inc. stock outperform tech sector in 2025Forecast Cut & Short-Term High Return Ideas - Улправда
How Doximity Inc. stock compares to industry benchmarksWeekly Market Report & Technical Confirmation Alerts - DonanımHaber
How higher bond yields impact Doximity Inc. Class stockDollar Strength & High Accuracy Trade Alerts - DonanımHaber
How Doximity Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - DonanımHaber
How rising interest rates impact Doximity Inc. stockBond Market & Weekly Breakout Opportunity Watchlist - Улправда
Doximity (NASDAQ:DOCS) Hits New 12-Month LowShould You Sell? - MarketBeat
How Analyst Upgrades Highlighting AI Tools And Ad Shift Potential At Doximity (DOCS) Has Changed Its Investment Story - Yahoo Finance
Is Analyst Upgrades on AI Workflow and Pharma Ads Altering The Investment Case For Doximity (DOCS)? - Sahm
Doximity (DOCS): Assessing Valuation After Analyst Upgrades and Growing AI-Driven Growth Prospects - Sahm
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying By Investing.com - Investing.com South Africa
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends By Investing.com - Investing.com South Africa
Doximity stock hits 52-week low at 43.59 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.59 USD - Investing.com India
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying - Investing.com India
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends - Investing.com Nigeria
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event - Investing.com Nigeria
Texas Permanent School Fund Corp Acquires 82,274 Shares of Doximity, Inc. $DOCS - MarketBeat
How Doximity is looking to break through AI skepticism - Modern Healthcare News
Doximity (DOCS) ascends while market falls: Some facts to note - MSN
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note - sharewise.com
Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook - Yahoo Finance
Doximity Sees Surge as AI Tools and Analyst Ratings Impress - StocksToTrade
Is Doximity Now an Opportunity After Recent Share Price Slide? - Yahoo Finance
Doximity rises after Morgan Stanley upgrades to 'overweight' - TradingView — Track All Markets
Doximity upgraded at Morgan Stanley on expanding market for HCP platforms - MSN
Doximity (NASDAQ:DOCS) Shares Gap UpStill a Buy? - MarketBeat
Doximity Offers Attractive Entry Point, Morgan Stanley Says - marketscreener.com
Doximity’s underperformance at odds with improving business, says MS - Investing.com
Morgan Stanley Upgrades Doximity to Overweight From Equalweight, Raises Price Target to $65 From $62 - marketscreener.com
Morgan Stanley upgrades Doximity stock to Overweight on conservative outlook - Investing.com Canada
Doximity (DOCS) Stock Trends and Sentiment 2025 - MarketBeat
Doximity, Inc. (NYSE:DOCS) Q2 2026 Earnings Call Transcript - MSN
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
0.09%
자본화:
|
볼륨(24시간):